Quantiphi, a global AI-first digital engineering company, and DDReg, a global leader in regulatory expertise, has inked a partnership that will address regulatory challenges that pharmaceutical ...
Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...
Harbour BioMed submits IND application for HBM9378/SKB378 to China NMPA to treat chronic obstructive pulmonary disease: Suzhou, China Monday, November 11, 2024, 17:00 Hrs [IST] Ha ...
UDF to organize experts meeting towards creation of Indian Pharmaceutical Regulatory Service cadre: Shardul Nautiyal, Mumbai Monday, November 11, 2024, 16:45 Hrs [IST] New Delhi b ...
Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...
Dr Jayachandra Babu Ramapuram has been honoured with the prestigious AAPS Fellow Award at the American Association of Pharmaceutical Scientists (AAPS) annual meeting held in Salt Lake City, Utah. This ...
Robles BioCeutics collaborates with BioCentrium to explore the molecular mechanisms behind Glowselle stem cell activator: San Diego Monday, November 11, 2024, 16:00 Hrs [IST] Robl ...
EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...
US FDA advisory panel votes in favour of IceCure's ProSense cryoablation benefit-risk profile in early-stage low risk breast cancer: Caesarea, Israel Monday, November 11, 2024, 15 ...
Leucine Rich Bio, now unveils its #HappyGutMission campaign an initiative designed to educate people on the critical role of gut health. This campaign has brought gut health to the forefront, offering ...
US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours: Redmond, Washington Monday, November 11, 2024, 14:00 Hrs [IST] SystImmune, Inc (SystImmune), a ...